The association between the use of sodium glucose cotransporter 2 inhibitor and the risk of diabetic retinopathy and other eye disorders: a systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Clinical Pharmacology"
DOI: 10.1080/17512433.2022.2102973
Abstract: ABSTRACT Objective To assess the association between the use of sodium–glucose cotransporter 2 inhibitor (SGLT2i) and the incidence of diabetic retinopathy (DR). Research design and methods PubMed, Medline, Embase, the Cochrane Central Register of Controlled… read more here.
Keywords: use sodium; association use; sglt2i; risk ... See more keywords
Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors and Epilepsy: A Population-Based Study Using Target Trial Emulation.
Sign Up to like & getrecommendations! Published in 2025 at "Diabetes care"
DOI: 10.2337/dc24-2532
Abstract: OBJECTIVE Preclinical studies in animals have suggested potential neuroprotective effects of sodium-glucose cotransporter 2 inhibitors (SGLT-2is), but no epidemiological study has investigated the potential effects of SGLT-2is on epilepsy risk. We aimed to assess the… read more here.
Keywords: study; sglt 2is; epilepsy; association use ... See more keywords
Comment on Althobaiti et al. Potential Association between the Use of Anabolic Steroids and COVID-19 Infection. Healthcare 2022, 10, 196
Sign Up to like & getrecommendations! Published in 2022 at "Healthcare"
DOI: 10.3390/healthcare10071172
Abstract: Recently, Althobaiti, Y. S. and colleagues [...]. read more here.
Keywords: comment althobaiti; association use; potential association; althobaiti potential ... See more keywords